Search
for

    Sort by

    Research 151–180 of 1000+

    1. Sarcoïdose grave Revue des Maladies Respiratoires · 2014
    2. Nociceptive and Nonnociceptive Roles of TRPV3 and Its “Druggability” Methods in pharmacology and toxicology · 2012
    3. When two plus two must not equal four British Journal of Urology · 2011
    4. Skin endocrinology and nutrition Dermato-endocrinology · 2009
    5. CAN PATIENTS WITH LUTS AND BPH DISCERN CHANGES IN PEAK URINARY FLOW RATE AND DO SUCH CHANGES CONTRIBUTE TO OVERALL SATISFACTION WITH TREATMENT? The Journal of Urology · 2009
    6. Faculty Opinions recommendation of Association between 5-alpha reductase inhibition and risk of hip fracture. Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · 2008
    7. [Hirsutism]. PubMed · 2007
    8. Successes and failures of evidence based urology 2005
    9. Treatment response to conventional and novel therapies in chronic prostatitis Current Prostate Reports · 2003
    10. 40gm 미만의 전립선비대증에서 α-차단제와 Finasteride 병합요법의 유용성 2003
    11. Influencia del tratamiento con alfa bloqueantes e inhibidores de la 5 alfa reductasa en los hallazgos morfológicos e inmunohistoquímicos de la hiperplasia benigna de próstata Dialnet (Universidad de la Rioja) · 2002
    12. Metoprolol Reactions (Auckland) · 1982
    13. Contemporary techniques of hair replacement Postgraduate Medicine · 1981
    14. Catecholaminergic neurons boost fibroblast osteogenic activity in keloid Nature Communications · 2026
    15. PD49-03 IS TADALAFIL ASSOCIATED WITH DECREASED RISK OF MAJOR ADVERSE CARDIAC EVENTS OR VENOUS THROMBOEMBOLISM IN MEN WITH LOWER URINARY TRACT SYMPTOMS? 2022
    16. MP74-11 TRENDS IN THE PHARMACOTHERAPY OF NOCTURIA, 2016-2021: ANALYSIS OF A LARGE MULTI-INSTITUTIONAL RESEARCH NETWORK The Journal of Urology · 2023
    17. Dutasteride, finasteride: no increased risk of ED Reactions Weekly · 2016
    18. Mixture effects of endocrine disrupting compounds in vitro International Journal of Andrology · 2010 · 108 citations
    19. Treatment of female pattern hair loss with the androgen receptor antagonist flutamide Australasian Journal of Dermatology · 2011 · 30 citations
    20. Suppression of Wnt/β-catenin signaling by EGF receptor is required for hair follicle development Molecular Biology of the Cell · 2018 · 25 citations
    21. Dutasteride for the treatment of benign prostatic hyperplasia Expert opinion on pharmacotherapy · 2013 · 24 citations
    22. Minoxidil for Control of Acute Blood Pressure Elevation in Chronically Hypertensive Children Pediatrics · 1986 · 23 citations
    23. Pre-aggregation of scalp progenitor dermal and epidermal stem cells activates the WNT pathway and promotes hair follicle formation in in vitro and in vivo systems Stem Cell Research & Therapy · 2019 · 17 citations
    24. Human epithelial stem cell survival within their niche requires “tonic” cannabinoid receptor 1‐signalling—Lessons from the hair follicle Experimental Dermatology · 2021 · 14 citations
    25. Rational Design of a Topical Androgen Receptor Antagonist for the Suppression of Sebum Production with Properties Suitable for Follicular Delivery Journal of Medicinal Chemistry · 2010 · 11 citations
    26. Age‐dependent regulation by androgens of gene expression in the anterior hypothalamus and stress‐induced release of adrenal hormones in adolescent and adult male rats Journal of neuroendocrinology · 2019 · 10 citations
    27. Sodium Valproate Improves Skin Flap Survival via Gamma-Aminobutyric Acid and Histone Deacetylase Inhibitory System 2019 · 8 citations
    28. Metoprolol and alopecia. PubMed · 1981 · 5 citations
    29. Ovarian Stromal Hyperthecosis and Hyperandrogenemia Refractory to Hormonal Suppression Obstetrics and gynaecology cases - reviews · 2015 · 2 citations
    30. Pharmacological Profile of 9,11-Dehydrocortexolone 17α-Butyrate (CB-03-04), a New Androgen Antagonist with Antigonadotropic Activity Arzneimittelforschung · 2011 · 1 citations